Nisun International Enterprise Development Group Co., Ltd (NISN)

Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	45.02	114.45	63.9	91.45	22.14
Short-Term Investments	6.88	12.79	11.7	40.67	4.68
Cash & Short-Term Investments	51.9	127.24	75.6	132.11	26.82
Cash Growth	-59.21%	68.31%	-42.77%	392.67%	872.84%
Accounts Receivable	54.44	21.12	18.93	18.52	4.94
Other Receivables	23.98	59.17	43.48	59.79	25.69
Receivables	78.42	80.29	62.41	78.31	32.55
Inventory	0.81	30.95	31.61	3.98	-
Prepaid Expenses	25.89	16.02	10.89	4	0.97
Restricted Cash	-	0.2	3.42	0.18	0.06
Other Current Assets	94.3	38.6	46.97	9.21	-
Total Current Assets	251.33	293.3	230.89	227.8	60.4
Property, Plant & Equipment	1.97	3.27	4.07	0.94	2.12
Long-Term Investments	0.46	0.37	22.54	16.61	16.22
Goodwill	17.05	17.66	23.81	25.77	25.17
Other Intangible Assets	0.21	0.88	1.8	2.85	3.73
Long-Term Deferred Tax Assets	0.41	0.42	0.31	-	0.46
Total Assets	271.42	315.9	283.42	273.98	108.1
Accounts Payable	34.63	45.46	40.93	35	1.31
Accrued Expenses	4.94	8.99	8.03	5.77	2.98
Short-Term Debt	5.27	1.97	8.46	11.31	10.53
Current Portion of Leases	0.95	0.86	1.01	0.34	0.74
Current Income Taxes Payable	1.63	2.4	0.81	6.65	2.05
Other Current Liabilities	12.05	51.4	31.23	29.65	9.2
Total Current Liabilities	59.47	111.09	90.47	88.72	26.8
Long-Term Leases	0.82	1.64	2.43	0.15	0.68
Long-Term Deferred Tax Liabilities	-	0.11	0.73	0.5	0.68
Total Liabilities	60.29	112.84	93.62	89.38	28.16
Common Stock	0.05	0.04	0.04	0.04	0.02
Additional Paid-In Capital	139.71	130.54	130.5	130.32	59.47
Retained Earnings	85.75	79.96	62.38	44.76	14.38
Treasury Stock	-1.25	-0.26	-0.36	-	-
Comprehensive Income & Other	-17.49	-11.47	-6.94	5.51	2.97
Total Common Equity	206.76	198.8	185.63	180.63	76.84
Minority Interest	4.37	4.26	4.17	3.97	3.09
Shareholders' Equity	211.13	203.05	189.8	184.6	79.94
Total Liabilities & Equity	271.42	315.9	283.42	273.98	108.1
Total Debt	7.04	4.48	11.9	11.8	11.95
Net Cash (Debt)	44.86	122.77	63.7	120.31	14.87
Net Cash Growth	-63.46%	92.72%	-47.05%	709.09%	560.80%
Net Cash Per Share	11.07	31.13	15.98	55.94	8.00
Filing Date Shares Outstanding	4.61	3.95	3.94	3.98	2.06
Total Common Shares Outstanding	4.54	3.95	3.94	3.98	2.06
Working Capital	191.86	182.22	140.42	139.07	33.6
Book Value Per Share	45.56	50.30	47.07	45.37	37.38
Tangible Book Value	189.51	180.26	160.02	152	47.94
Tangible Book Value Per Share	41.76	45.61	40.57	38.18	23.32
Machinery	1.17	1.67	1.41	0.83	1.14
Leasehold Improvements	0.1	0.24	0.37	0.42	0.39

Updated Oct 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q